These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 1399926)

  • 21. Direct detection by real-time PCR of ftsI gene mutations affecting MICs of β-lactam agents for Haemophilus influenzae isolates from meningitis.
    Kishii K; Morozumi M; Chiba N; Ono A; Ubukata K
    J Infect Chemother; 2011 Oct; 17(5):671-7. PubMed ID: 21573861
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro interactions of amikacin and beta-lactam antibiotics against amikacin-resistant gram-negative bacilli.
    Alvarez S; Jones M; Holtsclaw-Berk S; Berk SL
    Chemotherapy; 1988; 34(2):107-12. PubMed ID: 3391050
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of the EUCAST disc diffusion susceptibility testing method for Haemophilus influenzae based on the resistance mechanism to β-lactam antibiotics.
    García-Cobos S; Arroyo M; Pérez-Vázquez M; Aracil B; Oteo J; Campos J
    J Antimicrob Chemother; 2013 Jan; 68(1):159-63. PubMed ID: 23034712
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibiotic-induced release of endotoxin from bacteria in vitro.
    Crosby HA; Bion JF; Penn CW; Elliott TS
    J Med Microbiol; 1994 Jan; 40(1):23-30. PubMed ID: 8289210
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ampicillin-resistant Haemophilus influenzae isolates in Geneva: serotype, antimicrobial susceptibility, and β-lactam resistance mechanisms.
    Cherkaoui A; Diene SM; Emonet S; Renzi G; Francois P; Schrenzel J
    Eur J Clin Microbiol Infect Dis; 2015 Oct; 34(10):1937-45. PubMed ID: 26187432
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differences in neutrophil death among beta-lactam antibiotics after in vitro killing of bacteria.
    Matsuda T; Saito H; Fukatsu K; Han I; Inoue T; Furukawa S; Ikeda S; Hidemura A; Kang W
    Shock; 2002 Jul; 18(1):69-74. PubMed ID: 12095137
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Lysis of Pathogenic Escherichia coli by Bacteriophages Releases Less Endotoxin Than by β-Lactams.
    Dufour N; Delattre R; Ricard JD; Debarbieux L
    Clin Infect Dis; 2017 Jun; 64(11):1582-1588. PubMed ID: 28329379
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Comparative activity of oral beta-lactam antibiotics against fifty strains of Haemophilus influenzae producing a beta-lactamase according to bacterial inoculum].
    Gaillot O; Simonet M
    Pathol Biol (Paris); 1994 May; 42(5):375-7. PubMed ID: 7824299
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [In vitro effect of cefixime against Haemophilus influenzae].
    Dabernat H; Delmas C
    Presse Med; 1989 Oct; 18(32):1551-2. PubMed ID: 2530529
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The influence of protein binding on the antibacterial activity of faropenem against Haemophilus influenzae.
    Gustafsson I; Cars O
    Clin Microbiol Infect; 2004 Oct; 10(10):934-7. PubMed ID: 15373892
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential susceptibility of invasive Haemophilus influenzae serotype a and serotype b to ampicillin and other commonly prescribed antibiotics.
    Shuel M; Whyte K; Drew T; Wylie J; Lefebvre B; Hoang L; Tsang RS
    Lett Appl Microbiol; 2014 Aug; 59(2):193-9. PubMed ID: 24712310
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serotypes, antimicrobial susceptibility, and beta-lactam resistance mechanisms of clinical Haemophilus influenzae isolates from Bulgaria in a pre-vaccination period.
    Setchanova LP; Kostyanev T; Markovska R; Miloshev G; Mitov IG
    Scand J Infect Dis; 2013 Feb; 45(2):81-7. PubMed ID: 22992181
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antimicrobial-induced endotoxin and cytokine activity in an in vitro model of septicemia in foals.
    Bentley AP; Barton MH; Lee MD; Norton NA; Moore JN
    Am J Vet Res; 2002 May; 63(5):660-8. PubMed ID: 12013465
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Killing rate and growth rate comparison for newer beta-lactamase-stable oral beta-lactams against Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis.
    Yourassowsky E; Van der Linden MP; Crokaert F
    Chemotherapy; 1992; 38(1):7-13. PubMed ID: 1618006
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Concentration-dependency of beta-lactam-induced filament formation in Gram-negative bacteria.
    Buijs J; Dofferhoff AS; Mouton JW; Wagenvoort JH; van der Meer JW
    Clin Microbiol Infect; 2008 Apr; 14(4):344-9. PubMed ID: 18261128
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic approach to study the relationship between penicillin-binding protein 3 mutations and Haemophilus influenzae beta-lactam resistance by using site-directed mutagenesis and gene recombinants.
    Osaki Y; Sanbongi Y; Ishikawa M; Kataoka H; Suzuki T; Maeda K; Ida T
    Antimicrob Agents Chemother; 2005 Jul; 49(7):2834-9. PubMed ID: 15980357
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Antimicrobial activities of beta-lactam antibiotics against clinically isolated Haemophilus influenzae].
    Takahashi T; Tsujihara Y; Harada M; Shimura H; Takahashi S; Hachiya K; Matsumoto F; Takahashi S
    Jpn J Antibiot; 1999 Apr; 52(4):292-301. PubMed ID: 10396686
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [In vitro bactericidal activity of tobramycin and amikacin alone or in combination against Pseudomonas aeruginosa isolated from patients with cystic fibrosis].
    Bertrou A; Marty N; Henry S; Agueda L; Chabanon G
    Pathol Biol (Paris); 1990 May; 38(5):366-75. PubMed ID: 2114606
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro activity of rosoxacin against Haemophilus influenzae.
    Jurek EA; Weiner LB; Granato PA
    Chemotherapy; 1983; 29(4):262-4. PubMed ID: 6603337
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro activity of cefixime (CL284635) and other antimicrobial agents against Haemophilus isolates from pediatric patients.
    Kumar A; Kelly KJ
    Chemotherapy; 1988; 34(1):30-5. PubMed ID: 3258232
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.